Rotation Medical develops a rotator cuff system built around a proprietary bioinductive implant and disposable instruments for arthroscopic procedures. The implant, FDA‑cleared in March 2014, is designed to induce new tendon tissue growth, increase tendon thickness, and help heal tendon defects. The company launched the Rotation Medical rotator cuff system in fall 2014 and reports rapid physician adoption and positive market momentum. Rotation Medical intends to use the new financing to accelerate U.S. commercialization activities and expand its U.S. presence. The company was founded in 2009, is privately held, and is funded by New Enterprise Associates, Life Sciences Partners and Pappas Ventures. Rotation Medical develops the Rotation Medical rotator cuff system, a proprietary bioinductive implant paired with disposable instruments for mini-open and arthroscopic procedures. The bioinductive implant is designed to induce new tendinous tissue growth, increase tendon thickness, and heal tendon defects to reduce re-tears. The system aims to address limitations of current repair approaches that often do not correct poor underlying tendon quality. Rotation Medical received FDA 510(k) clearance for its implantable bioinductive implant in March 2014. The company, founded in 2009 and based in Plymouth, Minn., plans a U.S. commercial launch later this month and will conduct post-market clinical studies. It recently completed a financing to support commercialization and clinical work. Rotation Medical is a Plymouth, Minnesota-based medical technology firm that has changed names and in a recent SEC filing reclassified itself from biotech to "other healthcare." The company's specific products and operations are unclear; the article states that "what the company does is a mystery" and that founders/executives have been quiet. Rotation is led by Thomas Westling and previously operated as Denali Medical under founder Thomas Hektner, who remains on the board. Board members include John Nehra (special partner at NEA), Michael DeMane (former Medtronic COO, now CEO at Nevro), and Albert Graf (former Guidant president, venture partner at NEA). An April 14 regulatory filing shows the company has raised $10 million of a planned $15 million offering. The filing also indicates the company appears to have raised nearly $19 million since 2007, per SEC records. Rotation Medical is operating in stealth and provides few public details about its product; regulatory filings and press reporting suggest it is developing some form of medical device or medical-technology offering. The company was incorporated in 2006 and is based in Minnesota. Founder Thomas Hektner is a co-founder of StarFire Medical; Thomas A. Westling is listed as chief executive and president. Directors named in filings include former Medtronic executive Michael DeMane and New Enterprise Associates representatives Jay Graf, John Nehra and Dr. Ali Behbahani. Rotation has no revenue according to its SEC filing. The company has not maintained a public website and appears to be funding development privately while remaining largely under the radar.

Total raised

$53M

Funding rounds

4

Latest round

Series B

Latest activity

Aug 2016